Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Cardiology
•
Cardio-Obstetrics
What has been your approach to using contrast enhancement agent in the echo lab in pregnant patients if there is concern for LV thrombus or poor imaging windows for LVEF/valvular disease assessment?
Or would you recommend MRI instead?
Related Questions
When would be your threshold to switch to weight-based LMWH from warfarin for persistently subtherapeutic INR levels in a patient with a mechanical AVR in the first trimester?
If a pregnant patient with a mechanical heart valve takes warfarin throughout her pregnancy, what are the chances that the fetus will be harmed?
Given findings from the LIFE trial, are there any benefits in using Entresto over valsartan alone in HFrEF patients?
Is active cocaine or methamphetamine use a contraindication to implanting defibrillators?
Is there evidence to support empiric atrial flutter ablation for patients undergoing PVI for atrial fibrillation in the absence of clinical evidence of atrial flutter?
How soon would you repeat PET/CT in a patient with cardiac sarcoid after starting treatment with infliximab?
What is your stepwise approach to managing no re-flow during PCI?
How do you counsel an otherwise healthy patient on how soon they can go back to moderate exercise after a bilateral pulmonary embolism?
In a patient with cardiac light chain amyloid who has significant heart failure symptoms, including inotrope dependence at presentation, how much clinical benefit does treatment provide?
Do you prefer CTA or MRA for further imaging in patients with ascending aortic dilatation detected on TTE?